Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of GSK2186877A in Elderly Subjects
NCT00760617Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2008
- Primary completion
- May 2009
- Modality
- Whole Inactivated Vaccines
- Countries
- 3
01
Overview
A Phase 3 trial of GSK2186877A in influenza, sponsored by GSK. Started Oct 2008; status: completed.
02
Drugs
GSK2186877A
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00760617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00760617.